Trial intelligence / Profile preview

Sildenafil Citrate in Japanese Patients with Pulmonary Arterial Hypertension

NCT00454207Phase 3Completed

Sponsor
Viatris
Start
Apr 2007
Primary completion
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sildenafil in pulmonary arterial hypertension (PAH), sponsored by Viatris. Started Apr 2007; status: completed.

02

Drugs

sildenafil
03

Conditions

pulmonary arterial hypertension (PAH)

Beyond the preview

Go deeper on NCT00454207.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00454207.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call